- Home
- / Satsuma Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Satsuma Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.1
2023-06-09
Market Capitalization
$36.8 M
2023-06-09
CreditSafe Score
?
Score changed on Jul 19, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|
| General and administrative expense | 754.0K | 1.1M | 4.7M | 12.1M | 13.5M | 15.1M |
| Operating expense total | 4.9M | 7.5M | 28.9M | 48.3M | 59.2M | |
| EBIT | (4.9M) | (7.5M) | (28.9M) | (48.3M) | (51.2M) | (70.9M) |
| Interest income | 30.0K | 72.0K | 1.2M | 1.1M | 157.0K | 905.0K |
| Interest expense | 15.0K | 90.0K | ||||
| Income tax expense | 1.0K | 1.0K | ||||
| Net Income | (5.2M) | (7.3M) | (28.2M) | (47.6M) | (51.2M) | (70.1M) |
| EPS | (2.2) |